Triomics has secured $22 million in new funding to support the deployment of AI solutions tailored for oncology in cancer treatment centers. The company aims to advance AI-driven methods for improving cancer care and operational efficiency within these facilities.
Researchers have discovered a common weakness found across hundreds of cancer mutations, paving the way for potential new treatments. The study highlights how artificial intelligence tools support understanding complex genetic patterns in cancer. The breakthrough may help in the development of targeted therapies.
A new artificial intelligence tool has shown remarkable accuracy in predicting the spread of cancer, according to recent research. The technology promises to enhance diagnostic precision and support clinical decision-making in oncology.
Researchers have used artificial intelligence to test and validate a longstanding theory on how cancer begins. The study showcases AI's potential to uncover complex biological patterns, contributing to a deeper understanding of cancer formation.
A new artificial intelligence model demonstrates remarkable accuracy in forecasting the spread of cancer. The technology could significantly improve diagnosis and treatment planning by providing faster and more precise predictions of cancer metastasis.
European startups are accelerating the development of next-generation cancer diagnostics and treatments, leveraging artificial intelligence, biotechnology, and novel research environments. Companies highlighted include developers of AI-powered screening devices, personalised drug simulations, and innovations in cancer care delivery. These advancements aim to improve early detection, enhance therapy effectiveness, and reduce treatment side effects across Europe.
A recent study underscores the dangers of high-deductible health plans in the US, revealing increased mortality among cancer patients facing substantial out-of-pocket costs. The findings highlight the human and financial risks associated with rising healthcare costs and the growing popularity of high-deductible insurance.
Researchers have developed innovative nanoparticles capable of seeking out and destroying harmful protein aggregates linked to dementia and cancer, marking a potential breakthrough in targeted treatments. This advance, powered by artificial intelligence techniques, opens new pathways for precision medicine.
Recent research sheds light on the persistent challenge of immunotherapy resistance in cancer patients. By leveraging artificial intelligence, scientists are uncovering the complex mechanisms behind therapy failure, offering hope for more effective personalized treatments.
A groundbreaking study conducted by MIT's Shoulders lab reveals how a cellular protein-folding network allows cancer cells to tolerate and thrive on harmful genetic mutations, challenging traditional cancer treatment strategies and offering new therapeutic insight.
Stay informed with curated insights delivered weekly to your inbox.